Apostle Clinical Trials, Inc.

Long Beach, California 90813

0 studies enrolling now · 10 studies all time

What they study most

Alzheimer's Disease, Bipolar Disorder, Chronic Schizophrenia, Cognitive Dysfunction, Depression, Negative Symptoms, Schizophrenia, Schizophrenia and Predominant Negative Symptoms

Studies at this site

• Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension — Completed
• Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms — Completed
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression — Completed
• Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients — Completed
• Lurasidone Low-Dose - High-Dose Study Study — Completed
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. — Completed
• Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia — Completed
• Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia — Completed
• Switching to Iloperidone From Other Antipsychotics in Schizophrenia — Completed